Professor Douglas Kell

Professor of Bioanalytical Science

Douglas Kell studied at Oxford University focusing for his D. Phil. on the development and exploitation of novel methods for the study of (mainly microbial) bioenergetics.

He was awarded a Personal Chair at the University College of Wales (now Aberystwyth University) in 1992 and from 1998-2002 was Director of Research of the Institute of Biological Sciences.  He co-founded Aber Instruments that received the Queen's Award for Export Achievement in 1998.

In 2002 he accepted an RSC/EPSRC-funded Chair in Bioanalytical Sciences at UMIST.  From 2005-2008 he was Director of the Manchester Centre for Integrative Systems Biology at the University of Manchester.  He chaired Manchester’s e-science review (2013/14).

From 2008 until 2013 he was seconded as Chief Executive of BBSRC (0.8 FTE).

He has a Doctor of Science Honoris Causa from the Universities of Cranfield (2012), East Anglia (2015) and Aberdeen (2015).  He is a Fellow of the Learned Society of Wales (2012), the American Association for the Advancement of Science (2013), Aberystwyth University (2014) and a Lifetime Honorary Fellow of The Metabolomics Society (2013).  Douglas was awarded a CBE for services to science and research in the Queen’s New Year’s Honours 2014.

He has been a pioneer in many areas of computational biology and experimental metabolomics, including the use of evolutionary, closed-loop methods for optimisation. He also contributed to the discovery of the first bacterial cytokine, currently on trial as part of a vaccine against tuberculosis.

He has published over 400 scientific papers with >23,000 citations in WoK (H-index 77).  In Google Scholar H=95 and citations >37,000.